Brain MRI atrophy quantification in MS: From methods to clinical application.
Patients with the main clinical phenotypes of multiple sclerosis (MS) manifest varying degrees of brain atrophy beyond that of normal aging. Assessment of atrophy helps to distinguish clinically and cognitively deteriorating patients and predicts those who will have a less-favorable clinical outcome...
主要な著者: | Rocca, M, Battaglini, M, Benedict, R, De Stefano, N, Geurts, J, Henry, R, Horsfield, M, Jenkinson, M, Pagani, E, Filippi, M |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
American Academy of Neurology
2016
|
類似資料
-
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI
著者:: Houshang Amiri, 等
出版事項: (2018-01-01) -
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis.
著者:: Vrenken, H, 等
出版事項: (2013) -
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis
著者:: Vrenken, H, 等
出版事項: (2013) -
Relaxometry and brain myelin quantification with synthetic MRI in MS subtypes and their associations with spinal cord atrophy
著者:: Theodoros Ladopoulos, 等
出版事項: (2022-01-01) -
Measurement of whole-brain and gray matter atrophy in multiple sclerosis: assessment with MR imaging
著者:: Storelli, L, 等
出版事項: (2018)